OREANDA-NEWS. On January 12, in San Francisco, CA, USA, there started functioning 33d annual J.P. Morgan Healthcare Conference that joined together world leaders of pharmaceutical industry and innovative biotechnological companies.

Representatives of over 300 private and state companies including all the world leading pharmaceutical companies as well about 5000 investors took part in one of the most important events of the year in the sphere of international healthcare.

Mr. Valisiy Ignat'ev, Director General of R-Pharm group of companies, took the floor in front of the participants of the international conference within the "Private Companies" panel and talked about the plans of establishing a global Russian pharmaceutical company. R-Pharm keeps demonstrating a steady growth of sales and carries out large-scale innovative projects on building medicines and active ingredients production facilities and research centers around the world. The group has already been presented in USA, Japan, CIS, Turkey, India and Germany. The main goal is development of R&D programs, expansion of potential markets for production and sales of self-developed and licensed innovations, growth of cooperation and partnership.